UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000062823
Receipt number R000066184
Scientific Title A Multicenter Randomized Controlled Trial to Evaluate the Effectiveness of a Decision Support Program for Patients with Hematological Malignancies Using a Prompt List of Questions and Coaching; MagiQ Study
Date of disclosure of the study information 2026/09/08
Last modified on 2026/09/08 08:48:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study to Evaluate the Effectiveness of a Decision Support Program Using a Question Prompt List and Nurse-led Navigation for Patients with Hematological Malignancies (MagiQ Study)

Acronym

MagiQ Study

Scientific Title

A Multicenter Randomized Controlled Trial to Evaluate the Effectiveness of a Decision Support Program for Patients with Hematological Malignancies Using a Prompt List of Questions and Coaching; MagiQ Study

Scientific Title:Acronym

MagiQ Study

Region

Japan


Condition

Condition

Adult patients newly diagnosed with diffuse large B-cell lymphoma, follicular lymphoma, multiple myeloma, or myelodysplastic syndrome who are scheduled to receive first-line treatment

Classification by specialty

Hematology and clinical oncology Nursing

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate whether a decision support program combining a Question Prompt List(QPL) with nurse-led navigation improves patients' satisfaction with decision support compared with usual care among patients with hematological malignancies.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

After consultation with the physician: Patients Satisfaction Questionnaire: PSQ

Key secondary outcomes

1. Preparation for decision making: Assessed after the physician consultation using the Japanese version of the Preparation for Decision Making Scale (J-PrepDM).
2. Level of anxiety: Assessed before randomization and after the physician consultation using the Generalized Anxiety Disorder-7 (GAD-7).
3. Number of questions asked by the patient: Assessed as the number of questions asked by the patient during the physician consultation.
4. Consultation duration: Measured from the beginning to the end of the physician consultation.
5. Acceptability of the intervention: Assessed among participants in the intervention group after the physician consultation in terms of the usefulness of the QPL and nurse-led navigation, ease of asking questions, willingness to use the intervention again, and appropriateness of its timing.
6. Qualitative data: A subset of participants in the intervention group will be contacted within two weeks after the intervention to arrange a semi-structured interview. The interview will qualitatively explore their experiences with the decision support program, its helpful aspects, and areas requiring improvement.
7. Appropriateness, acceptability, and feasibility for implementation: Physicians and nurses participating in the study will evaluate the appropriateness, acceptability, and feasibility of implementing the decision support program in clinical practice using a questionnaire and free-text responses after completion of the study.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom Maneuver

Interventions/Control_1

In addition to receiving the common booklet, participants will receive a single session of a decision support program consisting of nurse-led navigation using a Question Prompt List (QPL) for patients with hematological malignancies before the physician consultation.

Interventions/Control_2

Participants will receive usual care, including the common booklet provided to both groups.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients who are able to communicate in Japanese.
2. Patients who have received a sufficient explanation of the study, fully understood its content, and provided written informed consent to participate of their own free will.

Key exclusion criteria

1. Patients with a history of chemotherapy or radiotherapy.
2. Patients whom a physician judges to be unable to participate in the study because of a marked decline in physical functioning or severe distress.
3. Patients with a serious psychiatric disorder or dementia.

Target sample size

292


Research contact person

Name of lead principal investigator

1st name Yuki
Middle name
Last name Shirai

Organization

Kansai Medical University

Division name

Faculty of Nursing and Graduate School of Nursing

Zip code

573-1004

Address

2-2-2 Shin-machi, Hirakata City, Osaka-fu

TEL

072-804-0148

Email

shirai.yuk@kmu.ac.jp


Public contact

Name of contact person

1st name Miharu
Middle name
Last name Morikawa

Organization

Graduate School of Medicine, Kyoto University

Division name

Oncology Nursing and Palliative Care, Human Health Sciences

Zip code

606-8507

Address

53 ShogoinKawaramachi, Sakyo-ku, Kyoto-shi, Kyoto-fu

TEL

080-6205-3266

Homepage URL

https://saqra.jp/studies/study/qbvw6ht5ni

Email

magiqstudy@gmail.com


Sponsor or person

Institute

Kansai Medical University

Institute

Department

Personal name

Yuki Shirai


Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Supporting Center for Clinical Research and Education (SaQRA)
Graduate School of Medicine, Kyoto University
National Cancer Center Japan
The Jikei University School of Medicine
Shizuoka Cancer Center

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kansai Medical University

Address

2-5-1Shin-machi, Hirakata City, Osaka-fu

Tel

072-804-0101

Email

rinriirb@kmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

関西医科大学附属病院(大阪府)、社会医療法人北楡会 札幌北楡病院(北海道)、医療法人 菊郷会 愛育病院(北海道)、岩手県立中央病院(岩手県)、東京慈恵会医科大学附属柏病院(千葉県)、東京慈恵会医科大学附属病院(東京都)、日本赤十字社 京都第二赤十字病院(京都府)、日本赤十字社大阪赤十字病院(大阪府)、近畿大学奈良病院(奈良県)、佐世保市総合医療センター(長崎県)


Other administrative information

Date of disclosure of the study information

2026 Year 09 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 08 Month 17 Day

Date of IRB

2026 Year 08 Month 17 Day

Anticipated trial start date

2026 Year 09 Month 28 Day

Last follow-up date

2028 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 09 Month 04 Day

Last modified on

2026 Year 09 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066184